Cizzle Biotechnology Holdings PLC (GB:CIZ) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Cizzle Biotechnology Holdings PLC, a UK-based diagnostics developer, has announced their Annual General Meeting (AGM) for shareholders on June 24, 2024, at the offices of Shakespeare Martineau LLP in London. The company, which is pioneering a blood test for the early detection of lung cancer through a stable plasma biomarker called CIZ1B, has made the AGM details available on their website. Cizzle Biotechnology’s innovation stems from research by Professor Coverley and colleagues at the University of York.
For further insights into GB:CIZ stock, check out TipRanks’ Stock Analysis page.